Aptamer Group
Pre-clinicalDevelops custom aptamer reagents and solutions for diagnostics, therapeutics, and research applications.
Founded
2008
Focus
DiagnosticsAntibodiesDrug Delivery
About
Develops custom aptamer reagents and solutions for diagnostics, therapeutics, and research applications.
Funding History
5Total raised: $23.7M
IPO$10MZeus CapitalMay 12, 2022
Series A$5.5MMercia Asset ManagementJun 15, 2020
Series A$5.5MUndisclosedJun 15, 2019
Seed$1.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2008
LocationYork, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile